In older adults, an AS01E-adjuvanted RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease

Research output: Contribution to journalArticlepeer-review

Abstract

Papi A, Ison MG, Langley JM, et al; AReSVi-006 Study Group. Respiratory syncytial virus prefusion F protein vaccine in older adults. N Engl J Med. 2023;388:595-608. 36791160.

Original languageEnglish (US)
Pages (from-to)JC62-JC63
JournalAnnals of Internal Medicine
Volume176
Issue number6
DOIs
StatePublished - Jun 1 2023

Keywords

  • Humans
  • Aged
  • Respiratory Syncytial Virus Infections/prevention & control
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Respiratory Syncytial Virus Vaccines/therapeutic use
  • Respiratory Tract Diseases

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'In older adults, an AS01E-adjuvanted RSVPreF3 OA vaccine reduced RSV-related lower respiratory tract disease'. Together they form a unique fingerprint.

Cite this